NRX Pharmaceuticals, Inc.

The momentum for this stock is not very good. NRX Pharmaceuticals, Inc. is not very popular among insiders. NRX Pharmaceuticals, Inc. is a mediocre stock to choose.
Log in to see more information.
NRXP Fundamental Data by TradingView

News

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com

PR Newswire NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com PR Newswire RADNOR, Pa., Sept. 11, 2024 'How NRx Could Upend...\n more…

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024

PR Newswire NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 NRx Pharmaceuticals...\n more…

HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion

Benzinga HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP),\n more…

NRx Pharmaceuticals reports potential acquisition and financing agreements
NRx Pharmaceuticals reports potential acquisition and financing agreements

Seeking Alpha - Healthcare NRx Pharmaceuticals reports potential acquisition and financing agreements...\n more…

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Cl
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Cl

PR Newswire HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics...\n more…

NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript
NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript

SeekingAlpha NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript...\n more…